Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely candesartan cilexetil 16 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely methylprednisolone 16 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely tiagabine hydrochloride 16 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely perphenazine 16 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely caffeine 30 milligram and dihydrocodeine tartrate 16 milligram and paracetamol 356.4 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely phenobarbital 16 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely phenobarbital 16 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
3 |
Product containing precisely caffeine 30 milligram and dihydrocodeine tartrate 16 milligram and paracetamol 356.4 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
3 |
Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram and codeine phosphate 16 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely ondansetron 16 milligram/1 each conventional release rectal suppository |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely hydromorphone hydrochloride 16 milligram/1 each prolonged-release oral capsule |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely chloroquine phosphate 16 milligram/1 milliliter conventional release oral solution |
Has concentration strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely ferric ammonium citrate 16 milligram/1 milliliter and folic acid 500 microgram/1 milliliter conventional release oral solution |
Has concentration strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release oral suspension |
Has concentration strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel |
Has concentration strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely ferric ammonium citrate 16 milligram/1 milliliter and folic acid 100 microgram/1 milliliter conventional release oral solution |
Has concentration strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely bevacizumab 400 milligram/16 milliliter conventional release solution for injection vial |
Has presentation strength denominator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely sulfamethoxazole 800 milligram/10 milliliter and trimethoprim 160 milligram/10 milliliter conventional release solution for infusion ampule |
Has concentration strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment |
Has concentration strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
3 |
Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has concentration strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely betahistine dihydrochloride 16 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely propranolol hydrochloride 16 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely paracetamol 16 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely necitumumab 16 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Betahistine 16mg tablets (Milpharm Ltd) |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Candesartan 16mg tablets (Milpharm Ltd) |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Betahistine 16mg tablets (Milpharm Ltd) 84 tablet |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Candesartan 16mg tablets (Milpharm Ltd) 28 tablet |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Candesartan 16mg tablets (Xiromed) |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Candesartan 16mg tablets (Xiromed) 28 tablet 2 x 14 tablets |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Candesartan 16mg tablets (Torrent Pharma (UK) Ltd) |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Candesartan 16mg tablets (Torrent Pharma (UK) Ltd) 28 tablet |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Betahistine 16mg tablets (Flamingo Pharma (UK) Ltd) |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |
Betahistine 16mg tablets (Flamingo Pharma (UK) Ltd) 84 tablet 6 x 14 tablets |
Has presentation strength numerator value |
False |
16 |
Inferred relationship |
Existential restriction modifier |
1 |